Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;20(1):267-269.
doi: 10.1111/jth.15580. Epub 2021 Nov 22.

Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al

Fien A von Meijenfeldt  1 , Sebastian Havervall  2 , Jelle Adelmeijer  1 , Charlotte Thalin  2 , Ton Lisman  1
Affiliations
Comment

Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al

Fien A von Meijenfeldt et al. J Thromb Haemost. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Comment in

Comment on

  • Persistent endotheliopathy in the pathogenesis of long COVID syndrome.
    Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, Englert H, Byrne M, Bergin C, O'Sullivan JM, Martin-Loeches I, Nadarajan P, Bannan C, Mallon PW, Curley GF, Preston RJS, Rehill AM, McGonagle D, Ni Cheallaigh C, Baker RI, Renné T, Ward SE, O'Donnell JS; Irish COVID-19 Vasculopathy Study (iCVS) investigators. Fogarty H, et al. J Thromb Haemost. 2021 Oct;19(10):2546-2553. doi: 10.1111/jth.15490. Epub 2021 Sep 12. J Thromb Haemost. 2021. PMID: 34375505 Free PMC article.

References

    1. Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(10):2546‐2553. - PMC - PubMed
    1. von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Sustained prothrombotic changes in COVID‐19 patients 4 months after hospital discharge. Blood Adv. 2021;5(3):756‐759. - PMC - PubMed
    1. von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality. Res Pract Thromb Haemost. 2020;5(1):132‐141. - PMC - PubMed
    1. Dietrich K, Ball GD, Mitchell LG. Increased plasminogen activator inhibitor results in a hypofibrinolytic state in adolescents with obesity: in vivo and ex vivo evidence. Br J Haematol. 2016;175(2):300‐307. - PubMed
    1. Hulshof AM, Braeken DCW, Ghossein‐Doha C, et al. Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge. Res Pract Thromb Haemost. 2021;5(6):e12579. - PMC - PubMed